
James Brugarolas MD PhD
Genitourinary Oncology, Hematologic Oncology
Director, Kidney Cancer Program; Sherry Wigley Crow Endowed Chair in Cancer Research; Professor of Internal Medicine/ Hematology-Oncology, Cancer Biology, Genetics, Development and Disease at UT Southwestern Medical Center
Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-4673
Fax+1 214-645-2542
Dr. Brugarolas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
Clinical Expertise
- Kidney Neoplasms, Renal cell carcinoma, Urologic oncology, Hematologic oncology
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2001 - 2003
Duke University HospitalResidency, Internal Medicine, 1998 - 2001
Massachusetts Institute of TechnologyPhD, Biology, 1993 - 1998
Universidad de Navarra Faculty of MedicineClass of 1993
Certifications & Licensure
TX State Medical License 2006 - 2026
MA State Medical License 2002 - 2007
NC State Medical License 1998 - 2004
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected member Association of American Physicians, 2025
- Principal Investigator, Kidney Cancer Specialized Program of Research Excellence (SPORE) National Cancer Institute
- Elected to the American Society for Clinical Investigation 2013
- Join now to see all
Publications & Presentations
PubMed
- HIF-2-dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear Cell Renal Cell Carcinoma.Arijit Mal, Bingqing Xie, Zane Gray, Charlotte Small, Susmita G Ramanand
Cancer Discovery. 2025-10-09 - Extracranial Palliative Radiation Therapy for Renal Cell Carcinoma.Young Suk Kwon, Eric Hsu, Maggie Stein, Alana Christie, Aurelie Garant
Advances in Radiation Oncology. 2025-10-01 - MorphoITH: a framework for deconvolving intra-tumor heterogeneity using tissue morphology.Aleksandra Weronika Nielsen, Hafez Eslami Manoochehri, Hua Zhong, Vandana Panwar, Vipul Jarmale
Genome Medicine. 2025-09-19
Press Mentions
UTSW Builds AI-Driven System to Improve Data CollectionJuly 28th, 2025
HMN 2025: How Cancer Cells Exploit Various Pathway to Assemble Antioxidant Lipids and Evade Cell DemiseJune 14th, 2025
Children’s Research Institute Scientists Uncover Unique Pathway Tumors Use to Acquire Antioxidant LipidsJune 11th, 2025- Join now to see all
Grant Support
- University of Texas Southwestern Medical Center SPORE in Kidney CancerUT SOUTHWESTERN MEDICAL CENTER2016–2027
- Specialized Program of Research Excellence (SPORE)NIH/NCI2016–Present
Committees
- Chair, Scientific Advisory Board, National Kidney Cancer Academy 2020 - Present
- Chair, Congressionally Directed Medical Research Program – Kidney Cancer Research Program 2017 - 2018
Professional Memberships
- Member
- Member
- American Society for Clinical Investigation - ASCIMember
Other Languages
- Spanish
External Links
- Kidney Cancer Programhttp://www.utsouthwestern.edu/kidneycancer
- Brugarolas Labhttp://www.brugarolaslab.com
- Kidney Cancer SPOREhttps://trp.cancer.gov/spores/kidney.htm
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:












